热卖商品
新闻详情
Merrimack Pharmaceuticals, Inc.(MACK)EPS | 财报说-AI巴菲特...
来自 : caibaoshuo.com/terms/MACK/...
发布时间：2021-03-25
Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA.
Merrimack Pharmaceuticals, Inc.截至2020年9月的季度基本每股收益计算为:基本每股收益(元) (EPS) = (净收入 - 优先股息) / 已发行股份基本平均数 截至2020年...财报说 财报 年报 季报 财务报表 财报分析 新手 入门 价值投资 A股 港股 美股 巴菲特 十倍股Merrimack Pharmaceuticals, Inc.(MACK)EPSMerrimack Pharmaceuticals, Inc.(MACK)EPS
本文链接： http://jpharmaceuticals.immuno-online.com/view-725038.html
发布于 ： 2021-03-25
阅读（0）
最新动态
2021-03-25
2021-03-25
2021-03-25
2021-03-25
2021-03-25
2021-03-25
2021-03-25
2021-03-25
2021-03-25
2021-03-25
2021-03-25
